Adult ALL Treatment at Diagnosis

Not Applicable

Completed

• Conditions: Leukemia, Lymphocytic, Acute

• Registration Number: NCT00537550
• Lead Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto

Brief Summary

The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-07
• Study Completion: 2006-06
• Status Verified: 2007-09
• Study First Submitted: 2007-09-27
• Study First Submitted QC: 2007-09-28
• Last Update Submitted: 2007-09-28
• Study First Posted: 2007-10-01
• Last Update Posted: 2007-10-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Diagnosis of acute lymphoblastic leukemia (ALL)
• Negative myeloperoxidase stain
• Phenotype T (ALL-T) and B(ALL-B)

Exclusion Criteria

• Creatinine > 2.5mg/dL after adequate hydratation
• LVEF <50%
• Presence of documented infections not responding to antibiotic and/or antifungal therapy
• Presence of concomitant malignant diseases
• Absence of any psychological condition that does not allow to intake high doses of cortisone
• Patients who have received any antineoplastic chemiotherapy for more than 5 days
• Patients who have received any steroids for more than 10 days

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (5)

Ist.Ematologia e Oncologia Medica L.e A. Seragnoli; 🇮🇹 Bologna, Italy

Ospedale Reg. A di Summa; 🇮🇹 Brindisi, Italy

Istituto di Ematologia- Ospedale San Carlo; 🇮🇹 Potenza, Italy

Policlinico G.B. Rossi; 🇮🇹 Verona, Italy

Az. Ospedaliera S. G. Moscati; 🇮🇹 Avellino, Italy